{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05285566",
            "orgStudyIdInfo": {
                "id": "21-008473"
            },
            "organization": {
                "fullName": "Mayo Clinic",
                "class": "OTHER"
            },
            "briefTitle": "Pain Control for Undergoing Costal Cartilage Harvesting",
            "officialTitle": "A Phase IV Randomized, Single-Blind Trial of Liposomal Bupivacaine (Exparel\u00ae) for Pain Control in Costal Cartilage Harvest",
            "therapeuticArea": [
                "Other"
            ],
            "study": "pain-control-for-undergoing-costal-cartilage-harvesting"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-05-04",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-08",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-09",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-03-09",
            "studyFirstSubmitQcDate": "2022-03-09",
            "studyFirstPostDateStruct": {
                "date": "2022-03-17",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-06",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-10",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Michael D. Olson, M.D.",
                "investigatorTitle": "Principal Investigator",
                "investigatorAffiliation": "Mayo Clinic"
            },
            "leadSponsor": {
                "name": "Mayo Clinic",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to find out whether injecting the U.S. Food and Drug Administration (FDA) approved drug EXPAREL\u00ae, a long acting (approximately 96 hours) numbing medication, will reduce pain after rib cartilage removal in comparison to the standard injection of XYLOCAINE\u00ae."
        },
        "conditionsModule": {
            "conditions": [
                "Nasal Surgery"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE4"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "SINGLE",
                    "whoMasked": [
                        "PARTICIPANT"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 60,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Exparel\u00ae Injection Group",
                    "type": "EXPERIMENTAL",
                    "description": "On the day of clinically indicated nasal surgery the surgical wound on the chest, where the rib cartilage is removed, will be injected with Exparel\u00ae",
                    "interventionNames": [
                        "Drug: Exparel"
                    ]
                },
                {
                    "label": "Xylocaine\u00ae Injection Group",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "On the day of clinically indicated nasal surgery the surgical wound on the chest, where the rib cartilage is removed, will be injected with Xylocaine\u00ae as part of standard of care.",
                    "interventionNames": [
                        "Drug: Xylocaine"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Exparel",
                    "description": "106mg (8 mL) subcutaneous injection injected after costal cartilage harvest",
                    "armGroupLabels": [
                        "Exparel\u00ae Injection Group"
                    ],
                    "otherNames": [
                        "Liposomal bupivacaine"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Xylocaine",
                    "description": "8 mL of 1% lidocaine with 1:100,000 of epinephrine into costal cartilage wound site",
                    "armGroupLabels": [
                        "Xylocaine\u00ae Injection Group"
                    ],
                    "otherNames": [
                        "Lidocaine"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Pain Scores",
                    "description": "Measured using a visual analog scale 0=no pain and 10=worst possible",
                    "timeFrame": "7-10 days following the last administration of study treatment"
                },
                {
                    "measure": "Change in oral pain medication",
                    "description": "Total oral pain medication usage self-reported in pain medication diary",
                    "timeFrame": "7-10 days following the last administration of study treatment"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Adverse Reactions",
                    "description": "Total number of adverse reactions reported to the study agent",
                    "timeFrame": "7-10 days following the last administration of study treatment"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Diagnosis of functional nasal obstruction or aesthetic nasal concern requiring nasal surgery with costal cartilage harvest.\n* Willing and able to understand and provide written informed consent.\n\nExclusion Criteria:\n\n* Known pregnancy.\n* Women who are currently nursing a child.\n* History of coagulopathy; such as hemophilia or Von Willebrand disease, or any congenital or acquired bleeding disorder.\n* Use of anticoagulation medication during the study, i.e. aspirin, Coumadin, Plavix, or medications similar in class to these medications will exclude the patient from participation.\n* Inability to provide informed consent (patients under guardianship).\n* Known hypersensitivity to local anesthetics\n* History of cardiac disease; such as current impaired cardiovascular function, past history of myocardial infarction, congenital heart disease, current cardiac symptoms, i.e. angina, shortness of breath, or chest pain as determined by history or review of the medical record.\n* History of complex pulmonary disease; such as uncontrolled asthma, COPD, or interstitial lung disease as determined by history or review of the medical record.\n\nImpaired renal function as documented in the medical record in the last 3 months with a serum creatinine greater than 1.2 mg/dL or glomerular filtration rate \\< 60 mL/min/BSA as determined by history or review of the medical record.\n\n- History of or current hepatic disease as documented by liver function test abnormality in the last 3 months as determined by history or review of the medical record.",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Amy Tuchscherer",
                    "role": "CONTACT",
                    "phone": "507-538-6582",
                    "email": "Tuchscherer.Amy@mayo.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Michael D Olson, MD",
                    "affiliation": "Mayo Clinic",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Mayo Clinic in Rochester",
                    "status": "RECRUITING",
                    "city": "Rochester",
                    "state": "Minnesota",
                    "zip": "55905",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Amy Tuchscherer",
                            "role": "CONTACT",
                            "email": "Tuchscherer.Amy@mayo.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.02163,
                        "lon": -92.4699
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M13066",
                    "name": "Pain",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008012",
                    "term": "Lidocaine"
                },
                {
                    "id": "D000002045",
                    "term": "Bupivacaine"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000779",
                    "term": "Anesthetics, Local"
                },
                {
                    "id": "D000000777",
                    "term": "Anesthetics"
                },
                {
                    "id": "D000002492",
                    "term": "Central Nervous System Depressants"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000018689",
                    "term": "Sensory System Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000000889",
                    "term": "Anti-Arrhythmia Agents"
                },
                {
                    "id": "D000061567",
                    "term": "Voltage-Gated Sodium Channel Blockers"
                },
                {
                    "id": "D000026941",
                    "term": "Sodium Channel Blockers"
                },
                {
                    "id": "D000049990",
                    "term": "Membrane Transport Modulators"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M7992",
                    "name": "Epinephrine",
                    "relevance": "LOW"
                },
                {
                    "id": "M11014",
                    "name": "Lidocaine",
                    "asFound": "Premature",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5315",
                    "name": "Bupivacaine",
                    "asFound": "Type",
                    "relevance": "HIGH"
                },
                {
                    "id": "M30371",
                    "name": "Racepinephrine",
                    "relevance": "LOW"
                },
                {
                    "id": "M211043",
                    "name": "Epinephryl borate",
                    "relevance": "LOW"
                },
                {
                    "id": "M4107",
                    "name": "Anesthetics",
                    "relevance": "LOW"
                },
                {
                    "id": "M4109",
                    "name": "Anesthetics, Local",
                    "relevance": "LOW"
                },
                {
                    "id": "M4213",
                    "name": "Anti-Arrhythmia Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M23177",
                    "name": "Sodium Channel Blockers",
                    "relevance": "LOW"
                },
                {
                    "id": "M30025",
                    "name": "Diuretics, Potassium Sparing",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "VaCoAg",
                    "name": "Vasoconstrictor Agents"
                },
                {
                    "abbrev": "Resp",
                    "name": "Respiratory System Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "AnArAg",
                    "name": "Anti-Arrhythmia Agents"
                },
                {
                    "abbrev": "ChanBlk",
                    "name": "Channel Blockers"
                },
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                }
            ]
        }
    },
    "hasResults": false
}